IGC Pharma (IGC) Change in Cash (2010 - 2025)
IGC Pharma (IGC) posted quarterly Change in Cash of $651000.0 for Q3 2025, up 334.17% year-over-year from $149940.3 in Q3 2024, and up 1228.57% quarter-over-quarter from $49000.0 in Q2 2025.
IGC Pharma (IGC) Change in Cash (2010 - 2025) Analysis & Trends
IGC Pharma (IGC) has reported Change in Cash for 16 consecutive years, with $651000.0 the latest figure, recorded in Q3 2025.
- In Q3 2025, Change in Cash rose 334.17% year-over-year to $651000.0; the TTM figure through Sep 2025 stood at -$441000.0 (up 70.2% YoY), while the FY2026 annual figure was -$693000.0, up 12.61% from the prior year.
- Change in Cash climbed to $651000.0 in Q3 2025 per IGC's latest filing, from $49000.0 in the prior quarter.
- Across five years, Change in Cash topped out at $13.6 million in Q1 2021 and bottomed at -$2.5 million in Q4 2021.
- Historically, Change in Cash has averaged $7210.5 across 5 years, with a median of -$1.1 million in 2024.
- On a YoY basis, Change in Cash climbed as much as 573.01% in 2021 and fell as far as 1243.17% in 2021.
- IGC Pharma's Change in Cash stood at -$2.5 million in 2021, then surged by 31.73% to -$1.7 million in 2022, then gained by 1.79% to -$1.6 million in 2023, then soared by 34.71% to -$1.1 million in 2024, then jumped by 160.5% to $651000.0 in 2025.
- Business Quant data shows IGC's Change in Cash at $651000.0 in Q3 2025, $49000.0 in Q2 2025, and -$65000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | IGC Pharma | 30.17 Mn | 29.90 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 651,000.00 |
| Jun 30, 2025 | 49,000.00 |
| Mar 31, 2025 | -65,000.00 |
| Dec 31, 2024 | -1.08 Mn |
| Sep 30, 2024 | -278,000.00 |
| Jun 30, 2024 | 626,000.00 |
| Mar 31, 2024 | -180,000.00 |
| Dec 31, 2023 | -1.65 Mn |
| Sep 30, 2023 | 1.30 Mn |
| Jun 30, 2023 | -1.47 Mn |
| Mar 31, 2023 | -1.75 Mn |
| Dec 31, 2022 | -1.68 Mn |
| Sep 30, 2022 | -1.43 Mn |
| Jun 30, 2022 | -2.41 Mn |
| Mar 31, 2022 | -1.48 Mn |
| Dec 31, 2021 | -2.46 Mn |
| Sep 30, 2021 | 1.08 Mn |
| Jun 30, 2021 | -1.23 Mn |
| Mar 31, 2021 | 13.58 Mn |
| Dec 31, 2020 | -183,000.00 |